Loading...

Pacific Blue™ anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_Blue_091207
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) Pacific Blue™ (filled histogram) or rat IgG2b, κ Pacific Blue™ isotype control (open histogram) (gated on total cells).
  • M1slash70_Blue_091207
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) Pacific Blue™ (filled histogram) or rat IgG2b, κ Pacific Blue™ isotype control (open histogram) (gated on total cells).
Compare all formats See Pacific Blue™ spectral data
Cat # Size Price Quantity Check Availability Save
101223 25 µg NOK776
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101224 100 µg NOK1774
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with Pacific Blue™ under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 1.0 µg per 106 cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Pacific Blue™ has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue™ conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zaman R, et al. 2021. Immunity. :. PubMed
  2. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  3. Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed
  4. Chen G, et al. 2021. J Mol Cell Cardiol. 159:62. PubMed
  5. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  6. Jauch-Speer SL, et al. 2022. Elife. 11: . PubMed
  7. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  8. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  9. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  10. Cai S, et al. 2023. J Clin Invest. 133: . PubMed
  11. He Y, et al. 2023. Nat Commun. 14:691. PubMed
  12. Kimura Y, et al. 2023. Front Immunol. 14:1070196. PubMed
  13. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  14. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  15. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  16. Liu PS, et al. 2023. Nat Immunol. 24:452. PubMed
  17. Golshadi M, et al. 2023. NPJ Regen Med. 8:12. PubMed
  18. Touré H, et al. 2023. PLoS Pathog. 19:e1011257. PubMed
  19. Herrejon Chavez F, et al. 2023. Nat Commun. 14:2290. PubMed
  20. Solier S, et al. 2023. Nature. 617:386. PubMed
  21. Wang C, et al. 2023. Int J Oral Sci. 15:19. PubMed
  22. Wang X, et al. 2023. Stem Cell Rev Rep. . PubMed
  23. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  24. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  25. Arora H, et al. 2019. Immunity. 50:418. PubMed
  26. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  27. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  28. Sharma-Chawla N, et al. 2016. Infect Immun . . PubMed
  29. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  30. Sharma A, et al. 2014. J Infect Dis. . PubMed
  31. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  32. Schneider C, et al. 2018. Cell. 174:271. PubMed
  33. Shen S, et al. 2018. Pain Med. 19:686. PubMed
  34. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  35. Castiello MC, et al. 2020. J Allergy Clin Immunol. . PubMed
  36. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  37. Silver AC, et al. 2018. Heliyon. 4:e00579. PubMed
  38. Lino AC et al. 2018. Immunity. 49(1):120-133 . PubMed
  39. Zhu H, et al. 2018. Elife. 7:. PubMed
  40. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  41. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  42. Cheng G, et al. 2021. iScience. 24:102673. PubMed
  43. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  44. Janelsins B, et al. 2013. Blood. 121:2923. PubMed
  45. Uhl J, et al. 2019. J Cell Commun Signal. 13:209. PubMed
  46. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  47. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  48. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  49. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  50. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  51. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  52. Huang A, et al. 2014. Exp Cell Res. 15:326. PubMed
  53. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  54. Yang Y, et al. 2021. Nat Commun. 12:525. PubMed
  55. Rothweiler S, et al. 2019. Purinergic Signal. 0.885416667. PubMed
  56. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  57. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  58. Zhao X, et al. 2022. Cell Biosci. 12:3. PubMed
  59. Rogawski DS, et al. 2021. Nat Commun. 12:2792. PubMed
  60. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  61. Sitnik S, et al. 2020. Mol Ther Oncolytics. 17:190. PubMed
  62. Ummarino S, et al. 2021. Cells. 10:. PubMed
  63. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  64. Fang EF, et al. 2019. Nat Neurosci. 22:401. PubMed
  65. Taherzadeh Z, et al. 2010. Am J Physiol Heart Circ Physiol. 298:H1273. PubMed
  66. Endo J, et al. 2014. J Exp Med. 211:1673. PubMed
  67. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  68. Michael BD, et al. 2020. Cell Reports. 32(11):108150. PubMed
  69. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  70. Saravia J, et al. 2015. PLoS Pathog. 11: e1005217. PubMed
  71. Raines A, et al. 2013. Development. 140:2942. PubMed
  72. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  73. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  74. Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed
  75. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  76. Ruf B, et al. 2021. Cancer Immunol Res. 9:1024. PubMed
  77. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  78. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  79. Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed
  80. Li N, et al. 2021. eLife. 10:00. PubMed
  81. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  82. Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed
  83. Krishnamoorthy N, et al. 2015. J Immunol. 194:863. PubMed
  84. Krishnamurthy B, et al. 2015. Diabetes. 64: 3229-3238. PubMed
  85. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  86. Calcinotto A, et al. 2018. Nat Commun. 9:4832. PubMed
  87. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  88. Belgiovine C, et al. 2021. Eur J Immunol. 51:2677. PubMed
  89. Ren K, et al. 2022. Brain Behav. 12:e2456. PubMed
  90. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  91. Wu Y, et al. 2021. PLoS Negl Trop Dis. 15:e0010050. PubMed
  92. Qin Q, et al. 2021. Cell Reports. 35(8):109161. PubMed
  93. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  94. Cheng Y, et al. 2019. Cell Rep. 28:1703. PubMed
  95. Bijalwan M, et al. 2019. Sci Rep. 9:3444. PubMed
  96. Qian J, et al. 2021. Int J Mol Sci. 22:. PubMed
  97. Park HB, et al. 2020. Nat Microbiol. 1319:5. PubMed
  98. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  99. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  100. Jonas B, et al. 2016. PLoS One. 11: 0159189. PubMed
  101. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  102. Sun P, et al. 2022. Nat Commun. 13:6562. PubMed
  103. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  104. Zhang X, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  105. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  106. Gao Y, et al. 2020. Immunity. 52(6):1007-1021.e8. PubMed
  107. Kar S, Colino J, Snapper C 2016. J Immunol. 196: 4204 - 4213. PubMed
  108. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  109. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  110. Souza SP, et al. 2021. PLoS Pathog. 17:e1010081. PubMed
  111. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  112. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  113. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  114. Tomlinson JE, et al. 2020. J Neurosci Methods. 331:108483. PubMed
  115. Yeung F, et al. 2020. Cell Host & Microbe. 27(5):809-822. PubMed
  116. Vacca F, et al. 2020. eLife. 9:e54017.. PubMed
  117. Barman S, et al. 2016. Int Immunol. 28: 533 - 545. PubMed
  118. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  119. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  120. Tian Y, et al. 2020. JCI Insight. 5:00. PubMed
  121. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  122. Nacer A, et al. 2014. PLoS Pathog. 10:1004528. PubMed
  123. Agrawal M, et al. 2022. Blood. 140:1094. PubMed
  124. O'Leary CE, et al. 2021. Curr Protoc. 1:e77. PubMed
  125. Watson N, et al. 2015. J Immunol. 194:2796. PubMed
  126. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  127. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  128. Hill RZ, et al. 2018. Elife. 7:e33285. PubMed
  129. Sheppard S, et al. 2021. Cell Reports. 35(9):109210. PubMed
  130. Nguyen GT, et al. 2020. eLife. 9:e56656.. PubMed
  131. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  132. Hong S et al. 2018. Immunity. 49(4):695-708 . PubMed
  133. Jaitin DA et al. 2016. Cell. 167(7):1883-1896 . PubMed
  134. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  135. Tang S, et al. 2022. Virol J. 19:32. PubMed
  136. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  137. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  138. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  139. Vaas M, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16676825. PubMed
  140. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  141. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  142. Kratochvill F, et al. 2015. Cancer Res. 75: 3054-3064. PubMed
  143. Roberts L, et al. 2014. Infect Immun . 82:2504. PubMed
  144. Tomlinson JE, et al. 2018. J Neuroinflammation. 0.753472222. PubMed
  145. Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed
  146. Smith LK, et al. 2021. Elife. 10:. PubMed
  147. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  148. Stienstra R, et al. 2014. Diabetes. 63:4143. PubMed
  149. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  150. Parker K, Horn L, Ostrand-Rosenberg S 2016. J Leukoc Biol. 100: 463 - 470.. PubMed
  151. Young JS, et al. 2018. Front Immunol. 9:1385. PubMed
  152. Park SM et al. 2018. Cell stem cell. 24(1):153-165 . PubMed
  153. Mazumder S, et al. 2021. Heliyon. 7:e08124. PubMed
  154. Strait AA, et al. 2021. Commun Biol. 4:1005. PubMed
  155. Smith K, et al. 2012. Infect Immun . 80:3481. PubMed
  156. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  157. Denk F, et al. 2016. Cell Rep. 15: 1771-1781. PubMed
  158. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  159. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  160. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  161. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
  162. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  163. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
RRID
AB_755985 (BioLegend Cat. No. 101223)
AB_755986 (BioLegend Cat. No. 101224)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Spark YG™ 581 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
StarBright UltraViolet 575 anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 740 anti-mouse/human CD11b M1/70 FC
Spark PLUS V475™ anti-mouse/human CD11b M1/70 FC
Spark PLUS V450™ anti-mouse/human CD11b M1/70 FC
Spark PLUS YG581™ anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account